The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
 
Ghassan K. Abou-Alfa
No Relationships to Disclose
 
Stephen Lam Chan
No Relationships to Disclose
 
Masatoshi Kudo
No Relationships to Disclose
 
George Lau
No Relationships to Disclose
 
Robin Kate Kelley
No Relationships to Disclose
 
Junji Furuse
No Relationships to Disclose
 
Wattana Sukeepaisarnjaroen
No Relationships to Disclose
 
Yoon-Koo Kang
No Relationships to Disclose
 
Tu V. Dao
No Relationships to Disclose
 
Enrico N. De Toni
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Lilly; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Celsion; Roche
 
Lorenza Rimassa
No Relationships to Disclose
 
Valeriy Vladimirovich Breder
No Relationships to Disclose
 
Alexander Vasilyev
No Relationships to Disclose
 
Alexandra Heurgue
No Relationships to Disclose
 
Vincent Tam
No Relationships to Disclose
 
Kabir Mody
No Relationships to Disclose
 
Satheesh Chiradoni Thungappa
No Relationships to Disclose
 
Philip He
No Relationships to Disclose
 
Alejandra Negro
No Relationships to Disclose
 
Bruno Sangro
No Relationships to Disclose